We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$149M
AUM Growth
+$18.4M
Cap. Flow
+$15.4M
Cap. Flow %
10.36%
Top 10 Hldgs %
23.06%
Holding
807
New
78
Increased
152
Reduced
163
Closed
88

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$837K
2
ENB icon
Enbridge
ENB
+$643K
3
ABBV icon
AbbVie
ABBV
+$597K
4
IVZ icon
Invesco
IVZ
+$518K
5
CVS icon
CVS Health
CVS
+$501K

Top Sells

Rank Stock Value
1
VGK icon
Vanguard FTSE Europe ETF
VGK
+$1.23M
2
DEM icon
WisdomTree Emerging Markets High Dividend Fund
DEM
+$1M
3
BX icon
Blackstone
BX
+$893K
4
VTV icon
Vanguard Morningstar Value ETF
VTV
+$869K
5
VUG icon
Vanguard Morningstar Growth ETF
VUG
+$304K

Sector Composition

Rank Sector Weight
1 Technology 14.14%
2 Healthcare 10.85%
3 Consumer Staples 8.36%
4 Industrials 8.19%
5 Communication Services 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OLN icon
576
Olin
OLN
$2.12B
$7K ﹤0.01%
319
+5
+2% +$111
SCHP icon
577
Schwab US TIPS ETF
SCHP
$16.3B
$7K ﹤0.01%
266
– –
SNPS icon
578
Synopsys
SNPS
$79.7B
$7K ﹤0.01%
+55
New +$6.62K
SSYS icon
579
Stratasys
SSYS
$774M
$7K ﹤0.01%
+232
New +$5.51K
UFI icon
580
UNIFI
UFI
$134M
$7K ﹤0.01%
400
– –
VFH icon
581
Vanguard Financials ETF
VFH
$13.6B
$7K ﹤0.01%
95
– –
WEC icon
582
WEC Energy
WEC
$35.1B
$7K ﹤0.01%
79
– –
XOMA
583
DELISTED
Xoma
XOMA
$7K ﹤0.01%
443
– –
PVLA
584
Palvella Therapeutics
PVLA
$2.27B
$7K ﹤0.01%
18
– –
ATRS
585
DELISTED
Antares Pharma, Inc.
ATRS
$7K ﹤0.01%
+2,099
New +$6.07K
CLDR
586
DELISTED
Cloudera, Inc.
CLDR
$7K ﹤0.01%
1,302
– –
PETX
587
DELISTED
Aratana Therapeutics, Inc.
PETX
$7K ﹤0.01%
1,450
-5,500
-79% -$24.7K
ALDX icon
588
Aldeyra Therapeutics
ALDX
$93.5M
$6K ﹤0.01%
990
– –
BLUE
589
DELISTED
bluebird bio
BLUE
$6K ﹤0.01%
4
– –
COLL icon
590
Collegium Pharmaceutical
COLL
$956M
$6K ﹤0.01%
448
– –
DOC icon
591
Healthpeak Properties
DOC
$14.8B
$6K ﹤0.01%
200
-55
-22% -$1.71K
EDIT icon
592
Editas Medicine
EDIT
$442M
$6K ﹤0.01%
247
– –
GDXJ icon
593
VanEck Junior Gold Miners ETF
GDXJ
$8.46B
$6K ﹤0.01%
157
– –
HRL icon
594
Hormel Foods
HRL
$13.8B
$6K ﹤0.01%
156
– –
KBWD icon
595
Invesco KBW High Dividend Yield Financial ETF
KBWD
$428M
$6K ﹤0.01%
300
– –
LULU icon
596
lululemon athletica
LULU
$14.6B
$6K ﹤0.01%
+32
New +$5.56K
NGNE icon
597
Neurogene
NGNE
$712M
$6K ﹤0.01%
125
– –
PSEC icon
598
Prospect Capital
PSEC
$1.17B
$6K ﹤0.01%
900
– –
RARE icon
599
Ultragenyx Pharmaceutical
RARE
$2.55B
$6K ﹤0.01%
94
– –
RELL icon
600
Richardson Electronics
RELL
$304M
$6K ﹤0.01%
1,000
– –
22 23
24
25 26

Similar funds

CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
TC
Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $552M AUM 5.23% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Truvestments Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Truvestments Capital held 807 positions worth $149M, up 14% from $130M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Truvestments Capital deployed $15.4M of net new capital in Q2 2019, opening 78 new positions and adding to 152 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 4,043 shares worth $862K.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Vanguard FTSE Europe ETF, an estimated $1.23M trimmed.

  • Truvestments Capital's largest Q2 2019 buy was Berkshire Hathaway Class B: 4,043 shares worth $862K.
  • Truvestments Capital added most to Enbridge in Q2 2019, an estimated $643K increase.
  • Truvestments Capital's biggest Q2 2019 reduction was Vanguard FTSE Europe ETF, cutting an estimated $1.23M.
  • Truvestments Capital fully exited Blackstone in Q2 2019, selling an estimated $893K.
  • Truvestments Capital's ten largest holdings make up 23% of its $149M portfolio in Q2 2019.
  • Truvestments Capital opened 78 new positions and closed 88 in Q2 2019.
  • Truvestments Capital's portfolio value rose 14% quarter-over-quarter to $149M.

Based on Truvestments Capital's 13F filing for Q2 2019, filed 15 Jul 2019.